icon

Medworxx and the High Commission of Canada to the United Kingdom will Host a Clinical Utilisation Review Event at Canada House

News Release

TORONTO, ONTARIO, June 19, 2015 – Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) announced today the company’s sponsorship of an interactive thought leadership event taking place at The High Commission of Canada headquarters in London, called Canada House, on June 22, 2015. Medworxx is slated to provide unique insight into improving hospital and health system integration performance. The patient flow software company has invited NHS England representatives to answer key Clinical Utilisation Review (CUR) questions, including;  Peter Huskinson, Commercial Director, Specialised Commissioning at NHS England. Mr. Huskinson will address “Opportunities for Health System Wide Reform” and Karen Kelly, Operation Director, Barnsley NHS Foundation Trust will demonstrate “CUR benefits in Secondary Care.”

NHS England has introduced a substantial Commissioning for Quality and Innovation scheme (CQUIN) to support providers in adopting CUR technology for specialised admitted patient care and critical care in 2015/16.  “Our event agenda emphasizes the value placed on the application of evidence based objective criteria in ensuring appropriate patient care whilst identifying opportunities for whole system transformation,” stated, Peter Ellis, Managing Director of Medworxx UK.  “The goal of the event is to inform providers about improving patient flow, enhancing quality and ensuring patients are treated in the most appropriate clinical settings, freeing up staff time and hospital resources.”

Medworxx is increasingly being sought out to help organisations transform care delivery by redesigning inefficient processes and re-thinking business intelligence. The Medworxx solution combines a unique methodology, process, communication, technology, and clinical information as a decision support tool for all levels of an organisation.  The Medworxx Patient Flow Platform provides hospitals with tools to bridge clinical and operational assessments on daily patient flow – optimal for health care systems addressing issues of overcapacity, wait times and care coordination.

Limited space is available: Click here to register.

About Medworxx

Medworxx delivers health information technology solutions to over 400 hospitals internationally, including Canada, United States, United Kingdom, France and Australia.  Medworxx helps hospitals meet patient flow challenges and requirements for compliance and education. Medworxx Clinical Criteria —the flagship component of Medworxx Patient Flow, which also includes electronic bed management and independent assessment components—is currently used to manage 32% of the acute-care beds in Canada as well as acute-care beds in a rapidly increasing number of Trusts and CCGs  in the UK. Founded in 2004, Medworxx Inc. is based in Toronto, Canada, and publicly traded on the TSX Venture Exchange: MWX. Visit: www.medworxx.com    

Disclaimer

The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.

Media Contact

 

Peter Ellis
Managing Director

Medworxx UK

T: +44.(0)20.7730.9614

pellis@medworxx.com | www.medworxx.com

Dan Matlow
President & Chief Executive Officer
Medworxx
700 – 121 Richmond St West, Toronto,
Canada M5H 2K1
T: 1.800.321.1591 | T: 416.642.1278 x311
dmatlow@medworxx.com| www.medworxx.com

 

 

Date: 
June 18, 2015